MedPath

Neuropsychological Consultation as Part of Pediatric Diabetes Care: Does it Improve Glycemic Control and Family Functioning?

Not Applicable
Completed
Conditions
Glycinemia
Diabetes
Interventions
Behavioral: Usual standard of care
Behavioral: Neuropsychological Consultation
Registration Number
NCT03653013
Lead Sponsor
NYU Langone Health
Brief Summary

This is a randomized controlled open label study design (study team will not be blinded) to measure whether including targeted neuropsychological consultations as part of pediatric diabetes care informs treatment and educational planning, improves glycemic control, and improves quality of life. Patients will be randomized 1:1 ratio to Group 1-Control group and Group 2-Neuropsychological consultation group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • diagnosed with type 1 diabetes and followed for their care at the NYU pediatric diabetes center
  • English speaking families
Read More
Exclusion Criteria
  • not english speaking
  • diagnosed with type 1 diabetes within the last 6 months
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control GroupUsual standard of careUsual standard of care from their diabetes care team
Neuropsychological Consultation GroupNeuropsychological ConsultationChildren will be administered a number of neuropsychological tests. Children and parents in Group 2 will also complete a pediatric quality of life scale (PedsQL, Generic Scale and Diabetes Module), diabetes related family conflict scale (DFCS-R) to assess quality of life and family stress at the start of the study, as well as the self-report form of the BRIEF-2 if they are over age 11. Parents will also undergo a brief literacy and numeracy screening using the Wide Range Achievement Test, complete a parent report assessing their children's executive functioning skills at the start of the study (BRIEF-2) and they will fill out the Family Impact Module.
Primary Outcome Measures
NameTimeMethod
Improved Glycemic Control measured by assessment of glycemic control (HgbA1C)9 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath